Do you know what are advanced breast cancer, locally advanced breast cancer, or metastatic breast cancer in clinical trial eligibility criteria? Learn the terminologies here.
Metastatic Breast Cancer Awareness Day is a day selected to focus on MBC. Learn the experiences of living with MBC and ways how you can help.
This month, we begin a series about how scans are used to diagnose metastatic disease, look for new sites of metastasis, monitor progression, and assess treatment response.
You may wonder if you can go to doctor’s visits or participate in a clinical trial while continuing to work. Read more here about what to consider when continuing to work during treatment and trials.
You may wonder if you can go to doctor’s visits or participate in a clinical trial while continuing to work. Read more here about what to consider when continuing to work during treatment and trials.
To qualify for Tecentriq®-based immunotherapy, the cancer must test positive for the PD-L1 protein. Learn what researchers have found about PD-L1 and other biomarkers to identify patients suited for immunotherapy.
Depression is common after a metastatic breast cancer diagnosis, whether caused by treatment or emotional stress. To learn more about depression after a metastatic diagnosis and the impact of seeking support, check out the links in this issue.
In June, Living Beyond Breast Cancer (LBBC) held its Annual Conference on Metastatic Breast Cancer virtually. Read previews of the metastatic breast cancer research-based presentations here.
Young women diagnosed with metastatic breast cancer often have unique experiences because of the career, family and social features of their age. Learn more.
Young women diagnosed with metastatic breast cancer often have unique experiences because of the career, family and social features of their age. Learn more.
